Microbiotix, Inc
Publicly observedWorcester, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Worcester | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Microbiotix, Inc | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | SCNKBDM341T1 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant22 Sept 2025Publicly observed
NIH SBIR/STTR award: Novel Benzyl-Piperidine antifungal agents to treat intractable Mucorales infections
USD 299,381.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant22 Sept 2025Publicly observed
NIH SBIR/STTR award: Novel Benzyl-Piperidine antifungal agents to treat intractable Mucorales infections
USD 299,946.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant8 Aug 2025Publicly observed
NIH SBIR/STTR award: Development of well tolerated novel Inhibitors of drug resistant CMV
USD 289,318.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant8 Aug 2025Publicly observed
NIH SBIR/STTR award: Development of well tolerated novel Inhibitors of drug resistant CMV
USD 298,582.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant12 Apr 2024Publicly observed
NIH SBIR/STTR award: Proof of concept experiments for T3SS inhibitors against burn wound infections
USD 300,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant12 Aug 2022Publicly observed
NIH SBIR/STTR award: Discovery of Bunyaviral Endonuclease Inhibitors for Anti Viral
USD 969,050.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant12 Aug 2022Publicly observed
NIH SBIR/STTR award: Discovery of Bunyaviral Endonuclease Inhibitors for Anti Viral
USD 977,449.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.